Literature DB >> 26414732

Hyperuricemia, urate deposition and the association with hypertension.

G Mancia1, G Grassi2, C Borghi3.   

Abstract

Hyperuricemia is associated with hypertension, kidney disease, vascular and cardiovascular (CV) events. In experimental models, the inhibition of hepatic uricase induces hyperuricemia, hypertension and mild renal disease. Notably, the micro- and macrovascular changes observed in the experimental model of hyperuricemia resemble the histological changes of human hypertension. This paper presents and discusses the epidemiological correlation between high serum uric acid levels and hypertension, and reviews current evidence supporting the protective effects of the normalization of uric acid levels. This review is based on a PubMed/Embase database search for articles on hyperuricemia and its impact on cardiovascular and renal function.

Entities:  

Keywords:  Gout; Hypertension; Hyperuricemia; Kidney disease

Mesh:

Substances:

Year:  2015        PMID: 26414732     DOI: 10.1185/03007995.2015.1087981

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  13 in total

1.  Longitudinal transition trajectory of gouty arthritis and its comorbidities: a population-based study.

Authors:  Chien-Fang Huang; Ju-Chi Liu; Hui-Chuan Huang; Shao-Yuan Chuang; Chang-I Chen; Kuan-Chia Lin
Journal:  Rheumatol Int       Date:  2016-12-21       Impact factor: 2.631

2.  Empagliflozin reduces blood pressure and uric acid in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Di Zhao; Hui Liu; Pingshuan Dong
Journal:  J Hum Hypertens       Date:  2018-11-15       Impact factor: 3.012

Review 3.  Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association.

Authors:  Samir G Mallat; Sahar Al Kattar; Bassem Y Tanios; Abdo Jurjus
Journal:  Curr Hypertens Rep       Date:  2016-10       Impact factor: 5.369

4.  Pharmacological effects of Chatuphalatika in hyperuricemia of gout.

Authors:  Vilasinee Hirunpanich Sato; Bunleu Sungthong; Prasob-Orn Rinthong; Narawat Nuamnaichati; Supachoke Mangmool; Savita Chewchida; Hitoshi Sato
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

5.  Relationship between serum uric acid and clustering of cardiovascular disease risk factors and renal disorders among Shanghai population: a multicentre and cross-sectional study.

Authors:  Min Tao; Xiaoling Pi; Xiaoyan Ma; Yingfeng Shi; Yuzhen Zhang; Hongwei Gu; Yongbin Chi; Shougang Zhuang; Na Liu
Journal:  BMJ Open       Date:  2019-03-01       Impact factor: 2.692

6.  The association of gout with an increased risk of hypertension and diabetes mellitus among stroke survivors in New Zealand: A cross-sectional study using routinely collected electronic health data.

Authors:  Dina Eufemia D San Gabriel; Julia Slark
Journal:  JRSM Cardiovasc Dis       Date:  2019-07-19

Review 7.  Physiology of Hyperuricemia and Urate-Lowering Treatments.

Authors:  Caroline L Benn; Pinky Dua; Rachel Gurrell; Peter Loudon; Andrew Pike; R Ian Storer; Ciara Vangjeli
Journal:  Front Med (Lausanne)       Date:  2018-05-31

8.  The fatty liver index (FLI) and incident hypertension: a longitudinal study among Chinese population.

Authors:  Kena Zhou; Jie Cen
Journal:  Lipids Health Dis       Date:  2018-09-11       Impact factor: 3.876

9.  Hypouricemic Effects of Extracts from Urtica hyperborea Jacq. ex Wedd. in Hyperuricemia Mice through XOD, URAT1, and OAT1.

Authors:  Surina Han; Rongrui Wei; Daorina Han; Jixiao Zhu; Weizao Luo; Wuliji Ao; Guoyue Zhong
Journal:  Biomed Res Int       Date:  2020-01-29       Impact factor: 3.411

10.  Aqueous and Methanol Extracts of Paullinia pinnata (Sapindaceae) Improve Monosodium Urate-Induced Gouty Arthritis in Rat: Analgesic, Anti-Inflammatory, and Antioxidant Effects.

Authors:  Pius Pum Tseuguem; Télesphore Benoît Nguelefack; Basile Ngnanmegne Piégang; Sorelle Mbankou Ngassam
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.